Tereza Martinu is a lung transplant respirologist and clinician-scientist with the Toronto Lung Transplant Program. Dr. Martinu obtained her Medical Degree from McGill University in Montreal, Canada. She subsequently completed training in Internal and then Pulmonary and Critical Care Medicine at Duke University, in North Carolina, USA, before joining the Duke Lung Transplant Program. She recently transitioned to the Toronto program in August of 2014. In her clinical time, Dr. Martinu cares for lung transplant patients and candidates with end-stage lung diseases. Her research studies focus on immunological and cellular mechanisms of chronic lung allograft dysfunction in humans as well as in animal models.
Dr. Martinu’s research focuses on mechanisms of chronic lung allograft dysfunction (CLAD). CLAD is the main obstacle to long-term survival after lung transplantation and it remains an untreatable and poorly understood condition. Dr. Martinu studies the role of Th17, IL-17, and other related cells and molecules, as well as epithelial injury in the development of airway and lung parenchymal fibrosis in animal models of lung transplantation. Dr. Martinu also runs several translational human studies that assess CLAD mechanistic pathways in research samples obtained from lung transplant patients. 

For a list of Dr. Martinu's publications, please visit PubMed or Scopus.

Assistant Professor – University of Toronto
Adjunct Assistant Professor – Duke University